Intermediates
| No. | Product name | CAS | Structural diagram | API | Status |
|---|---|---|---|---|---|
| 1 | 4-isothiocyanato-2-trifluoroMethylbenzonitrile | 143782-23-4 |  |
Enzalutamide | Commercial |
| 2 | 2-Fluoro-5-3-oxoisobenzofuran-13H-ylidenemethylbenzonitrile | 763114-25-6 |  |
Olaparib | Commercial |
| 3 | 2-fluoro-5-4-oxo-3,4-dihydrophthalazin-1-ylMethylbenzoic acid | 763114-26-7 |  |
Olaparib | Commercial |
| 4 | Dehydronandrolone Acetate | 2590-41-2 |  |
Fulvestrant | Commercial |
| 5 | 7a,17b-7-9-Bromononylestra-1,3,510-triene-3,17-diol | 875573-67-4 |  |
Fulvestrant | Commercial |
| 6 | Estra-1,3,510-triene-3,17-diol,7-9-4,4,5,5,5-pentafluoropentylthiononyl-,17-acetate,7a,17b- | 875573-69-6 |  |
Fulvestrant | Commercial |
| 7 | 7a,17b-7-9-4,4,5,5,5-Pentafluoropentylthiononyl-estra-1,3,510-triene-3,17-diol | 153004-31-0 |  |
Fulvestrant | Commercial |
| 8 | 1-4-BOC-piperidyl-4-iodopyrazole | 877399-73-0 |  |
Crizotinib | Commercial |
| 9 | tert-Butyl 4-4-4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl-1H-pyrazol-1-ylpiperidine-1-carboxylate | 877399-74-1 |  |
Crizotinib | Commercial |
| 10 | R-5-bromo-3-1-2,6-dichloro-3-fluorophenylethoxypyridin-2-amine | 877399-00-3 |  |
Crizotinib | Commercial |
| 11 | 7-Benzyloxy-4-chloro-6-methoxy-quinoline | 286371-49-1 |  |
Anlotinib | Commercial |
| 12 | 6-Methoxy-4-chloro-quinolin-7-0l | 205448-31-3 |  |
Anlotinib | Commercial |
| 13 | Phenol, 2-fluoro-3-2-methyl-1,3-dioxolan-2-ylmethyl-4-nitro- | 2408629-32-1 |  |
Anlotinib | Commercial |
| 14 | benzyl 1-hydroxymethylcyclopropylcarbamate | 103500-22-7 |  |
Anlotinib | Commercial |
| 15 | 5-isothiocyanato-3-trifluoromethylpicolinonitrile | 951753-87-0 |  |
Apalutamide | Commercial |
| 16 | S-tert-Butyl 3-4-aminophenylpiperidine-1-carboxylate | 1171197-20-8 |  |
Niraparib | Commercial |
| 17 | 3-Formyl-2-nitrobenzoic acid methyl ester | 138229-59-1 |  |
Niraparib | Commercial |
